Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Genetic therapy for pain management.

S P Wilson1, D C Yeomans

  • 1Department of Pharmacology and Physiology, University of South Carolina School of Medicine, Columbia, SC 29208, USA. swilson@med.sc.edu

Current Review of Pain
|November 4, 2000
PubMed
Summary

Genetic therapy shows promise for chronic pain management. Two novel approaches using gene transfer in animal models successfully reduced pain signaling, paving the way for potential human therapies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Detection of prions from spiked and free-ranging carnivore feces.

Scientific reports·2024
Same author

Leptin activation of dorsal raphe neurons inhibits feeding behavior.

bioRxiv : the preprint server for biology·2023
Same author

Discovery of a selective, state-independent inhibitor of Na<sub>V</sub>1.7 by modification of guanidinium toxins.

Scientific reports·2020
Same author

Nasal application of HSV encoding human preproenkephalin blocks craniofacial pain in a rat model of traumatic brain injury.

Gene therapy·2017
Same author

GENETIC DRIFT IN SMALL POPULATIONS OF TRIBOLIUM.

Evolution; international journal of organic evolution·2017
Same author

Comparative sensitivity of aquatic invertebrate and vertebrate species to wastewater from an operational coal mine in central Queensland, Australia.

Ecotoxicology and environmental safety·2016

Area of Science:

  • Neuroscience
  • Genetics
  • Pharmacology

Background:

  • Chronic pain affects millions globally, with limited effective treatments.
  • Genetic therapy offers a novel strategy for long-term pain management.
  • Current pain management often relies on opioids, leading to addiction and side effects.

Purpose of the Study:

  • To investigate two distinct genetic therapy approaches for chronic pain management in animal models.
  • To assess the efficacy of transgene-mediated delivery and neuronal phenotype alteration in reducing pain.
  • To explore the potential of these genetic strategies for human clinical application.

Main Methods:

  • Transgene-mediated delivery of antinociceptive molecules to the cerebrospinal fluid via engineered cell lines and recombinant adenoviruses.
  • Alteration of nociceptive neuron phenotype using recombinant herpes viruses to overexpress antinociceptive peptides or reduce endogenous pain molecule expression.
  • Evaluation of pain attenuation in established animal pain models.

Main Results:

  • Both investigated genetic therapy approaches demonstrated significant attenuation or reversal of persistent nociceptive states in animal models.
  • Transgene delivery to the cerebrospinal fluid effectively introduced antinociceptive molecules.
  • Modifying neuronal phenotype via viral vectors successfully altered pain signaling pathways.

Conclusions:

  • Genetic therapy approaches, including transgene delivery and neuronal modulation, are effective in preclinical pain models.
  • These findings support the development of genetic therapies for managing chronic pain in humans.
  • Further research is warranted to translate these findings into safe and effective clinical treatments.

Related Experiment Videos